The influence of ACE inhibitors and ARBs on hospital length of stay and sur- vival in people with COVID-19

During the COVID-19 pandemic the continuation or cessation of angiotensinconverting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality with no lite...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14501

Acceso en línea:

https://doi.org/10.1016/j.ijcha.2020.100660
http://hdl.handle.net/20.500.12010/14501

Palabra clave:

Coronavirus
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Hospitalization
Hospital Mortality
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)